Nanoviricides Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.88

+0.03 (+3.53%)

As of Feb 8, 2:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,459.1% upside

Low Target $21.60

Average Target $31.32

High Target $37.71

Current Price $0.88

Current
$0.88

Target
$31.32

$21.60 $31.32 avg $37.71

Scenario Analysis

Bear Case

$21.60

2,354.5%

Low target

Base Case

$31.32

+3,459.1%

Avg target

Bull Case

$37.71

+4,185.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$38.78

-97.7% from high

52-Week Low

$24.92

+-96.5% from low

Target vs 52W High

$31.32

-19.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%